IvanJoseSunerMDMBA(He/Him)

PubMed

• 45 citations
  Identification of Patients With Diabetic Macular Edema From Claims Data: A Validation Study
  Srilaxmi Bearelly, Prithvi Mruthyunjaya, Janice P. Tzeng, Ivan J. Suñer, Alisa M. Shea
  Archives of Ophthalmology. 2008-07-14
• 143 citations
  Subretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials
  Alex S. Willoughby, Gui-Shuang Ying, Cynthia A. Toth, Maureen G. Maguire, Russell Burns
  Ophthalmology. 2015-09-01
• 154 citations
  A novel cytoarchitectonic area induced experimentally within the primate visual cortex.
  Pasko Rakic, Ivan Suner, Robert W. Williams
  Proceedings of the National Academy of Sciences of the United States of America. 1991-03-15

Journal Articles

• Responsiveness of the NEI-VFQ-25 to Visual Acuity Gains in Patients with Diabetic Macular Edema: Evidence from the RIDE and RISE Trials  
  Suner IJ, Bressler NM, Varma R, Dolan CM, Ward J, Trupcu A, Retina, 1/1/2017
• Diabetic Retinopathy Clinical Research Network, Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranib...  
  Wells JA, Glassman AR, Jampol LM, Aiello LP, Antoszyk AN, Baker CW, Bressler NM, Browning DJ, Connor CG, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun J..., JAMA Ophthalmol, 1/1/2016
• Effect of Ranibizumab on the Decision to Drive and Vision Function Relevant to Driving, in Patients with Diabetic Macular Edema: Report from RESTORE, RIDE, and RISE Tr...  
  Bressler NM, Varma R, Mitchell P, Suner IJ, Dolan C, Ward J, Ferreira A, Ehrlich J, Turpcu A, JAMA Ophthalmol, 1/1/2016
• Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)  
  Sharma S, Toth CA, Daniel E, Grunwald JE, Maguire MG, Ying GS, Huang J, Martin DF, Jaffe GJ; Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Re..., Ophthalmology, 1/1/2016
• Angiographic Cystoid Macular Edema and Outcomes in the Comparison of Age-Related Macular Degeneration Treatment Trials (CATT)  
  Shah N, Maguire MG, Martin DF, Shaffer J, Ying GS, Grunwald JE, Toth CA, Jaffe GJ, Daniel E; Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Re..., Ophthalmology, 1/1/2016
• Outcomes in Eyes with Retinal Angiomatous Proliferation in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)  
  Daniel E, Shaffer J, Ying GS, Grunwald JE, Martin DF, Jaffe GJ, Maguire MG; Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group, Ophthalmology, 1/1/2016
• Subretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatment Trials  
  Willoughby AS, Ying GS, Toth CA, Maguire MG, Burns RE, Grunwald JE, Daniel E, Jaffe GJ; Comparison of Age-Related Macular Degeneration Treatments Trials Research Group, Ophthalmology, 1/1/2015
• Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema  
  Diabetic Retinopathy Clinical Research Network, Wells JA, Glassman AR, Ayala AR, et. al, N Engl J Med, 1/1/2015
• RaScaL: A Pilot Study to Assess the Efficacy, Durability, and Safety of a Single Intervention with Ranibizumab + Peripheral Laser for Diabetic Macular Edema Associated...  
  Suner IJ, Peden MC, Hammer ME, Grizzard WS,Traynom J, Cousins SW, Ophthalmologica, 1/1/2015
• Incidence, Risk Factors, and Timing of Elevated Intraocular Pressure After Intravitreal Triamcinolone Acetonide Injection for Macular Edema Secondary to Retinal Vein O...  
  Aref AA, Scott IU, Oden NL, Ip MS, Blodi BA, VanVeldhuisen PC; SCORE Study Investigator Group, JAMA Ophthalmol, 1/1/2015
• Outcomes of Eyes with Lesions of >50% Blood in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)  
  Altaweel MM, Martin DE, Mittra RA, Grunwald JE, Lai MM, Melamud A, Morse LS, Huang J, Ferris FL 3rd, Fine SL, Maguire MG; CATT Research Group, Ophthalmology, 1/1/2015
• Topical nepafenec in eyes with noncentral diabetic macular edema  
  Friedman SM, Almukhtar TH, Baker CW, Glassman AR, Elman MJ, Bressler NM, Maker MP, Jampol LM, Melia M., et al, Retina, 1/1/2015
• Direct medical costs and resource use for treating central and branch retinal vein occlusion in commercially insured working-age and medicare populations  
  Suner IJ, Margolis J, Ruiz K, Tran I, Lee P, Retina, 1/1/2014
• Sporadic visual acuity loss in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)  
  Kim BJ, Ying GS, Huang J, Levy NE, Maguire MG; CATT Research Group, Am J Ophthalmol, 1/1/2014
• VEGFA and VEGFR2 gene polymorphisms and response to anti-vascular endothelial growth factor therapy: comparison of age-related macular degeneration treatments trials (...  
  Hagstrom SA, Ying GS, Pauer GJ, Sturgill-Short GM, Huang J, Maguire MG, Martin DF; Comparison of Age-Related Macular Degeneration Treatments Trials CATT Research Group, JAMA Ophthalmol, 1/1/2014
• Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials  
  Jaffe GJ, Martin DF, Toth CA, Daniel E, Maguire MG, Ying GS, Grunwald JE, Huang J, Comparison of Age-related Macular Degeneration Treatments Trials Research Group, Ophthalmology, 1/1/2013
• 12-Month Efficacy and Safety of 05 mg or 20 mg Ranibizumab in Patients with Subfoveal Neovascular Age-Related Macular Degeneration  
  Busbee BG, Ho AC, Brown DM, Heier JS, Suner IJ, Li Z, Rubio RG, Lai P, HARBOR Study Group, Ophthalmology, 1/1/2013
• Improved vision-related function after ranibizumab for macular edema after retinal vein occlusion: Results from the BRAVO and CRUISE Trials  
  Varma R, Bressler NM, Suner I, Lee P, Dolan CM, Ward J, Colman S, Rubio RG; BRAVO and CRUISE Study Groups, Ophthalmology, 1/1/2012
• Ranibizumab and bevacizumab for neovascular age-related macular degeneration: two-year results  
  CATT Research Group, Martin DF, Maguire MG, Fine SL, Ying GS, Jaffe GJ, Grunwald JE, Toth C, Redford M, Ferris FL 3rd, Ophthalmology, 1/1/2012
• Ranibizumab and bevacizumab for neovascular age-related macular degeneration  
  CATT Research Group, Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, Jaffe GJ, N Engl J Med, 1/1/2011
• Vision-related function after ranibizumab treatment by better- or worse-seeing eye: clinical trial results from MARINA and ANCHOR  
  Bressler NM, Chang TS, Suner IJ, Fine JT, Dolan CM, Ward J, Ianchulev T; MARINA and ANCHOR Research Groups, Ophthalmology, 1/1/2010
• Diagnosis and management of retinal vein occlusions  
  Spirin MJ, Regillo CD, Kaiser RS, Olsen TW, Freund KB, Gottlieb JL, Suner IJ, Retina Times, 1/1/2009
• Taking a broader view of diabetic macular edema  
  Suner IJ, Retinal Physician, 1/1/2009
• SCORE Study Report 7: incidence of intravitreal silicone oil droplets associated with staked-on vs luer cone syringe design  
  Scott IU, Oden NL, VanVeldhuisen PC, Ip MS, Blodi BA, Antoszyk AN; SCORE Study Investigator Group, Am J Ophthalmol, 1/1/2009
• Responsiveness of NEI VFQ-25 to changes in visual acuity in neovascular AMD: Validation studies from two phase 3 clinical trials  
  Suner IJ, Kokame GT, Yu E, Ward J, Dolan C, Bressler NM, Invest Ophthal Vis Sci, 1/1/2009
• Join now to see all

Books/Book Chapters

• Duane's Clinical Ophthalmology. 
  Chapter: Vitreous Substitutes-Gas, Fluid Viscoelastic, Silicone, Perfluorocarbon 
  Suner IJEditors: Tasman, W.S. and Jaeger, E.A.J.B. Lippincott Co, Philadelphia, PA2010
• Curbside Consultation in Retina: 49 Clinical Questions 
  Chapter: Panretinal Photocoagulation for Proliferative Diabetic Retinopathy 
  Suner IJEditors: Fekrat S.

Lectures

• Long-Term Continuous Treatment of Wet AMD with Anti-vascular Endothelial Growth Factor Agents (FIDO Study): 10-Year Results 
  Mykonos, Greece - 1/1/2017
• 10-Year Outcomes of Eyes Receiving Continuous, Fixed-Interval Dosing of Anti-Vascular Endothelial Growth Factor Agents for Neovascular Age-Related Macular Degeneration... 
  Boston, MA - 1/1/2017
• Long-term Outcomes in Eyes Receiving Fixed-Interval Dosing of Anti-vascular Endothelial Growth Factor Agents in Wet Age-Related Macular Degeneration (FIDO Study) 
  Paris, France - 1/1/2015
• Long-term Control of Macular Edema Associated with Branch Retinal Vein Occlusion with Combination Ranibizumab and Ultra-Wide Field Angiography-Guided Peripheral Scatte... 
  Las Vegas, NV - 1/1/2014
• REVOLUTIONARY: A Pilot Trial of Combination Peripheral Scatter Laser and Ranibizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion 
  San Diego, CA - 1/1/2014
• Revolutionary: Novel treatment paradigm for treatment of macular edema secondary to branch retinal vein occlusion associated with peripheral nonperfusion 
  Orlando, FL - 1/1/2014
• Improved Contrast Sensitivity in Retinal Vein Occlusion Patients after Treatment with Ranibizumab in BRAVO and CRUISE 
  Toronto, Ontario, Canada - 1/1/2013
• Efficacy and Safety of 2.0 mg and 0.5 mg Ranibizumab in Patients with Subfoveal Neovascular Age-Related Macular Degeneration: The HARBOR Study 
  Ft. Lauderdale, FL - 1/1/2012
• RaScaL Study: A novel treatment strategy for diabetic macular edema associates with peripheral retinal nonperfusion on ultrawide-field angiography 
  Abu Dhabi, United Arab Emirates - 1/1/2012
• The HARBOR Study: Effect of Every 4 Week versus PRN Dosing with Ranibizumab (2.0 mg vs 0.5 mg) on Patient-Reported Visual Function in Subfoveal Neovascular Age-Related... 
  Washington, DC - 1/1/2012
• Effects of Ranibizumab on Reading Speed Through 24 Months in Patients with Vision Impairment from Diabetic Macular Edema (DME) 
  Rome, Italy - 1/1/2011
• Improvements in Reading Speed After 6 Months of Ranibizumab Treatment in BRAVO and CRUISE 
  Ft. Lauderdale, FL - 1/1/2010
• RaScaL: A Pilot Study Assessing Efficacy of Ranibizumab + Peripheral Scatter Laser in DME Associated with Peripheral Nonperfusion 
  Vancouver, British Columbia, Canada - 1/1/2010
• RaScaL: A Prospective Clinical Trial Assessing Efficacy and Durability of Ultra-Widefield Angiography-Directed Scatter Laser Plus Ranibizumab in the Treatment of Diabe... 
  Kyoto, Japan - 1/1/2010
• Ultra-widefield angiography 
  Chicago, IL - 1/1/2010
• Vision-Related Mental Health Changes in Response to Ranibizumab Therapy in MARINA and ANCHOR 
  San Francisco, CA - 1/1/2009
• National Eye Institute Visual Function Questionnaire-25 (VFQ) Reading Items Improved Following Ranibizumab Treatment in MARINA and ANCHOR 
  Ft. Lauderdale, FL - 1/1/2009
• NEI VFQ-25 Outcomes in PIER within Subgroups Defined by OCT Fluid Status 
  New York, NY - 1/1/2009
• Improved Contrast Sensitivity in AMD Patients after Treatment with Ranibizumab in MARINA and ANCHOR 
  New York, NY - 1/1/2009
• Estimated Cases of Legal Blindness Avoided in the United States with Ranibizumab for Neovascular Age-Related Macular Degeneration 
  New York, NY - 1/1/2009
• Evaluating the Outcome in AMD Patients Who Stopped Receiving Constant Interval Dosing and Had a Recurrence of the Neovascular Process 
  New York, NY - 1/1/2009
• Neovascular AMD Patients in ANCHOR Who Still Drive Report More Control and Less Dependence on Others Than Those Who Do Not Drive 
  Maui, HI - 1/1/2008
• Relationship of Visual Acuity and NEI-VFQ-25 Visual Function in Exudative Age-Related Macular Degeneration 
  Ft. Lauderdale, FL - 1/1/2008
• Ultra-widefield angiography in the diagnosis of diabetic macular edema secondary to peripheral nonperfusion: clinical characteristics and a novel treatment strategy 
  Whistler, British Columbia, Canada - 1/1/2008
• Driving is associated with less vision-related dependency in neovascular AMD patients 
  Scottsdale, AZ - 1/1/2008
• Join now to see all

Other

• Measuring Quality of Life for Patients with Age-Related Macular Degeneration. 
  Matchar DB, Suner IJ, Samsa GP, McCrory DC, Cline K, Lee PP, Agency for Healthcare Research and Quality
  1/1/2006
• Influences of the lateral geniculate nucleus in the specification of primary visual cortex in Macaca mulatta. 
  Suner IJ, Doctoral thesis
  Yale University School of Medicine, New Haven, CT - 1/1/1992
• Studies in the purification of and the precocious induction of synthesis of juvenile hormone esterase in the tobacco hornworm, Manduca sexta. 
  Suner IJ, Honors thesis for Bachelor of Arts Degree, Department of Biology
  Harvard University, Cambridge, MA - 1/1/1988